default author photo

Jessica Wohlleben

Pfizer Deutschland GmbH

Germany

  • Pfizer Deutschland GmbH

SCHOLARLY PAPERS

1

DOWNLOADS

107

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Pneumococcal Vaccination Rates in Immunocompromised Patients in Germany: A Retrospective Cohort Study to Assess Sequential Vaccination Rates and Changes Over Time

Number of pages: 33 Posted: 05 Oct 2021
Ralf Sprenger, Dennis Häckl, Nils Kossack, Julia Schiffner-Rohe, Jessica Wohlleben and Christof von Eiff
Pfizer Pharma GmbH, Scientific Institute for Health Economics and Health System Research (WIG2 GmbH), Scientific Institute for Health Economics and Health System Research (WIG2 GmbH), Pfizer Deutschland GmbH, Pfizer Deutschland GmbH and Pfizer Pharma
Downloads 107 (654,668)

Abstract:

Loading...

pneumococcal vaccination rates, immunocompromised patients, sequential pneumococcal vaccination